Lumen Bioscience adds Jeff Raikes to board, promotes executives and secures $30M Series C extension led by WestRiver Group

Lumen Bioscience announced board and leadership changes—including Jeff Raikes joining as an independent director, promotions of Nhi Khuong and Kole Krieger, and appointment of David Saunders—and elected Erik Anderson as Vice Chairman. The company also closed an oversubscribed $30 million Series C extension led by WestRiver Group with participation from the Gates Foundation and several new investors to support its orally delivered biologics clinical pipeline.

JJeff Raikes LLumen Biosciences GGates Foundation WWestRiver Group